Joshua Cremin

Joshua Cremin has a diverse work experience in the field of scientific research. Joshua started their career in 2010 as a Summer Student at the University of Southampton, where they independently conducted research on the relationship between the diet of pregnant mice and the epigenome of their newborns. During this role, they gained experience in techniques such as SDS-PAGE, DNA extraction, and Western blotting.

In 2011, Joshua joined the Medical Research Council as a PHD Student. Joshua'sresearch focused on various molecular biology techniques, including PCR, restriction digests, ligation, plasmid transformation, and protein expression and purification using affinity chromatography. Joshua also gained expertise in liquid chromatography mass spectrometry analysis of intact protein masses.

Since 2016, Joshua has been working at Arecor Therapeutics plc. Joshua initially joined as a Scientist and was responsible for protein formulation research and development. Joshua utilized various HPLC analytical methods, including high-throughput screening with UPLC systems, and gained experience with Waters Acquity H-class and Thermo-Ultimate systems. Joshua also utilized techniques such as tangential flow filtration (TFF), micro-flow imaging (MFI), UV-vis spectroscopy, and Design of Experiments (DoE).

In September 2018, Joshua was promoted to the role of Senior Scientist at Arecor Therapeutics plc. In this position, they led multiple formulation projects for external partners and was also responsible for routine maintenance of HPLCs.

In November 2021, Joshua's role at Arecor Therapeutics plc was further elevated, and they currently serve as a Principal Scientist. Additional details about their current responsibilities and projects are not provided.

Joshua Cremin completed their education with a Bachelor's Degree in Biomedical Sciences from the University of Southampton, which they obtained between 2008 and 2011. Subsequently, they pursued further studies at the University of Cambridge, where they completed their doctoral studies in Structural Biology, earning a Doctor of Philosophy (Ph.D.) degree from 2011 to 2015.